Pyridoxine
Berocca Pn, Bonjesta, Diclegis, Infuvite, M.v.c. 9+, M.v.i, M.v.i. Lyophilized, Mvc, Pyridoxine, Tpn, Vitaped (pyridoxine) is a small molecule pharmaceutical. Pyridoxine was first approved as Bendectin on 1982-01-01. It is used to treat seizures and vitamin b 6 deficiency in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Pyridoxine (discontinued: Hexa-betalin, Pyridoxine)
CombinationsBonjesta, Diclegis, Doxylamine pyridoxine, Infuvite, Multiple vitamins injection (discontinued: Bendectin, Berocca pn, Doxylamine pyridoxine, M.v.c. 9+, M.v.i., M.v.i. lyophilized, Mvc, Tpn, Vitaped)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a palmitate
+
Vitamin e
Alpha-tocopherol acetate
+
Ascorbic acid
+
Biotin
+
Cholecalciferol
+
Cyanocobalamin
+
Dexpanthenol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a palmitate
+
Vitamin k
Ascorbic acid
+
Biotin
+
Cholecalciferol
+
Cyanocobalamin
+
Dexpanthenol
+
Folic acid
+
Niacinamide
+
Pyridoxine
+
Riboflavin
+
Thiamine
+
Tocopherol acetate
+
Vitamin a
+
Vitamin k
Doxylamine succinate
+
Pyridoxine hydrochloride
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Phytonadione
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine hydrochloride
+
Riboflavin 5'-phosphate sodium
+
Thiamine hydrochloride
+
Vitamin a
+
Vitamin e
+
Vitamin k
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pantothenic acid
+
Phytonadione
+
Pyridoxine
+
Riboflavin
+
Thiamine
+
Vitamin a palmitate
+
Vitamin e
Ascorbic acid
+
Biotin
+
Cyanocobalamin
+
Dexpanthenol
+
Ergocalciferol
+
Folic acid
+
Niacinamide
+
Pyridoxine
+
Riboflavin 5'-phosphate sodium
+
Thiamine
+
Vitamin a
+
Vitamin e
Niacinamide
+
Pyridoxine hydrochloride
+
Tyrosine
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| TPN | International Minerals | N-008378 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| animi-3 | unapproved drug other | 2013-02-06 |
| animi-3 with vitamin d | unapproved drug other | 2011-05-23 |
| bacmin | unapproved drug other | 2014-05-02 |
| bal-care dha | unapproved drug other | 2012-05-01 |
| bal-care dha essential | unapproved drug other | 2012-05-01 |
| bonjesta | New Drug Application | 2025-02-25 |
| bp vit 3 | unapproved drug other | 2026-06-19 |
| c-nate dha | unapproved drug other | 2024-01-22 |
| centratex | unapproved drug other | 2024-01-31 |
| citranatal | unapproved drug other | 2010-05-03 |
Show 84 more
Indications
FDA
EMA
Show 30 more
Agency Specific
FDA
EMA
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A11: Vitamins
— A11H: Other plain vitamin preparations in atc
— A11HA: Other plain vitamin preparations in atc
— A11HA02: Pyridoxine (vit b6)
J: Antiinfectives for systemic use
— J04: Antimycobacterials
— J04A: Drugs for treatment of tuberculosis
— J04AM: Combinations of drugs for treatment of tuberculosis
— J04AM08: Isoniazid, sulfamethoxazole, trimethoprim and pyridoxine
HCPCS
Code | Description |
|---|---|
| J3415 | Injection, pyridoxine hcl, 100 mg |
Clinical
Clinical Trials
820 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | 2 | 12 | 16 | 3 | 8 | 37 |
| Anemia | D000740 | EFO_0004272 | D64.9 | — | 4 | 7 | 3 | 21 | 34 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 2 | 12 | 4 | 10 | 29 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | 1 | 1 | 3 | 19 | 24 |
| Neoplasms | D009369 | — | C80 | 3 | 2 | 5 | 4 | 7 | 20 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 2 | 3 | 4 | 11 | 20 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 2 | — | 8 | 2 | 6 | 18 |
| Inflammation | D007249 | MP_0001845 | — | 2 | 2 | — | 2 | 11 | 17 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 1 | 5 | 2 | 4 | 5 | 15 |
| Syndrome | D013577 | — | — | — | 5 | 3 | 1 | 7 | 15 |
Show 112 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 7 | 4 | 1 | — | 17 | 29 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | 2 | 4 | — | 17 | 22 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 4 | 3 | — | 5 | 13 |
| Fatigue | D005221 | — | R53.83 | — | 3 | 2 | — | 5 | 10 |
| Hiv | D006678 | — | O98.7 | 2 | 2 | 3 | — | 3 | 9 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 1 | 3 | 1 | — | 6 | 9 |
| Colorectal neoplasms | D015179 | — | — | — | 2 | 2 | — | 5 | 8 |
| Pulmonary tuberculosis | D014397 | EFO_1000049 | A15 | 1 | 4 | 3 | — | 1 | 8 |
| Aids-related opportunistic infections | D017088 | — | — | 1 | — | 1 | — | 5 | 7 |
| Diarrhea | D003967 | — | R19.7 | — | — | 1 | — | 6 | 7 |
Show 122 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Depression | D003863 | — | F33.9 | 1 | 1 | — | — | 7 | 9 |
| Hypertension | D006973 | EFO_0000537 | I10 | 1 | 1 | — | — | 5 | 7 |
| Anxiety | D001007 | EFO_0005230 | F41.1 | 1 | 1 | — | — | 6 | 7 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | 1 | — | — | 5 | 6 |
| Autistic disorder | D001321 | EFO_0003758 | F84.0 | — | 2 | — | — | 4 | 6 |
| Autism spectrum disorder | D000067877 | — | F84.0 | — | 2 | — | — | 3 | 5 |
| Chronic pain | D059350 | — | — | — | 1 | — | — | 4 | 5 |
| Lymphoma | D008223 | — | C85.9 | 3 | 4 | — | — | — | 4 |
| Chronic fatigue syndrome | D015673 | EFO_0004540 | G93.31 | — | 2 | — | — | 2 | 4 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | 1 | — | — | 3 | 4 |
Show 70 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cognitive dysfunction | D060825 | — | G31.84 | 1 | — | — | — | 7 | 8 |
| Hip fractures | D006620 | EFO_0003964 | S72.00 | 1 | — | — | — | 2 | 3 |
| Allergic rhinitis | D065631 | — | J30.9 | 1 | — | — | — | 1 | 2 |
| Rhinitis | D012220 | EFO_0008521 | J31 | 1 | — | — | — | 1 | 2 |
| Biological availability | D001682 | — | — | 1 | — | — | — | 1 | 2 |
| Hyperkinesis | D006948 | — | — | 1 | — | — | — | 1 | 2 |
| Burns | D002056 | — | T30.0 | 1 | — | — | — | 1 | 2 |
| Heart rate | D006339 | EFO_0004326 | — | 1 | — | — | — | — | 1 |
| Triple negative breast neoplasms | D064726 | — | — | 1 | — | — | — | — | 1 |
| Myeloproliferative disorders | D009196 | — | D47.1 | 1 | — | — | — | — | 1 |
Show 9 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Body weight | D001835 | EFO_0004338 | — | — | — | — | — | 8 | 8 |
| Cognition | D003071 | EFO_0003925 | — | — | — | — | — | 6 | 6 |
| Premenstrual syndrome | D011293 | — | N94.3 | — | — | — | — | 6 | 6 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | — | — | — | 5 | 5 |
| Aggression | D000374 | EFO_0003015 | — | — | — | — | — | 4 | 4 |
| Metabolism | D008660 | GO_0008152 | — | — | — | — | — | 4 | 4 |
| Healthy diet | D000072001 | — | — | — | — | — | — | 4 | 4 |
| Diet therapy | D004035 | — | — | — | — | — | — | 3 | 3 |
| Headache | D006261 | — | R51 | — | — | — | — | 3 | 3 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | — | 3 | 3 |
Show 244 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Pyridoxine |
| INN | pyridoxine |
| Description | Pyridoxine is a hydroxymethylpyridine with hydroxymethyl groups at positions 4 and 5, a hydroxy group at position 3 and a methyl group at position 2. The 4-methanol form of vitamin B6, it is converted intoto pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters, sphingolipids and aminolevulinic acid. It has a role as a cofactor, a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a monohydroxypyridine, a vitamin B6, a member of methylpyridines and a hydroxymethylpyridine. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | Cc1ncc(CO)c(CO)c1O |
Identifiers
| PDB | — |
| CAS-ID | 65-23-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1364 |
| ChEBI ID | 16709 |
| PubChem CID | 1054 |
| DrugBank | DB00165 |
| UNII ID | KV2JZ1BI6Z (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Pyridoxine
+
Doxylamine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Pyridoxine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 9,999 documents
View more details
Safety
Black-box Warning
Black-box warning for: Citranatal, Citranatal assure, Citranatal essence, Citranatal harmony, Citranatal harmony 2.1, Healthy mamabe well rounded, Marnatal f, Moms choice rx, Natafort, Nestabs, Nestabs dha, O-cal prenatal vitamin, Pnv prenatal plus multivitamin, Pnv prenatal vitamin, Pnv-dha, Pnv-omega, Pnv-select, Pr natal 400, Pr natal 400 ec, Pr natal 430, Pr natal 430 ec, Pre-tabs dha, Prenata, Prenatal plus multivitamin plus dha minicaps, Prenate dha, Prenate elite, Prenate enhance, Prenate essential, Prenate mini, Prenate pixie, Prenate restore, Select ob, Select-ob plus dha, Tristart dha, Vitafol, Vitafol fe plus, Vitafol ob, Vitafol-ob plus dha
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
6,528 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use